35 results on '"Wanigasekera, Vishvarani"'
Search Results
2. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity
3. Systematic review and co‐ordinate based meta‐analysis to summarize the utilization of functional brain imaging in conjunction with human models of peripheral and central sensitization.
4. P103 Centralised pain in early rheumatoid arthritis predicts worse bodily pain outcomes
5. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)
6. Hippocampus mediates nocebo impairment of opioid analgesia through changes in functional connectivity
7. Imaging opioid mediated analgesia and hyperalgesia in healthy humans
8. Opioid suppression of conditioned anticipatory brain responses to breathlessness
9. SP8.2.4 Mindfulness-based Cognitive Therapy (MBCT) reduces symptoms in patients with chronic visceral pain, and is associated with the alteration of pain-evoked neural activity and resting functional connectivity in the descending pain modulatory system
10. Amygdala activity contributes to the dissociative effect of cannabis on pain perception
11. Author response for 'Hippocampus mediates nocebo impairment of opioid analgesia through changes in functional connectivity'
12. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
13. Imaging opioid analgesia in the human brain
14. Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects
15. P177 Investigating the neural differences in individuals with chronic widespread pain or fibromyalgia and the effect of sleep: a cross-sectional study using data from UK Biobank
16. Central Sensitization in Knee Osteoarthritis: Relating Presurgical Brainstem Neuroimaging and PainDETECT‐Based Patient Stratification to Arthroplasty Outcome
17. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
18. “Consensus on Placebo and Nocebo Effects Connects Science with Practice:” Reply to “Questioning the Consensus on Placebo and Nocebo Effects”
19. Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain
20. Response to “Treating patients rather than their functional neuroimages” (Br J Anaesth 2018; 121: 969–71)
21. Opioids for breathlessness: psychological and neural factors influencing response variability
22. Central Sensitization in Knee Osteoarthritis: Relating Presurgical Brainstem Neuroimaging and Pain DETECT ‐Based Patient Stratification to Arthroplasty Outcome
23. Sertraline or placebo in chronic breathlessness? Lessons from placebo research
24. Can Neuropathic Pain Predict Response to Arthroplasty in Knee Osteoarthritis? A Prospective Observational Cohort Study
25. Opioids decrease the unpleasantness of dyspnoea via actions in the medial prefrontal cortex
26. Disambiguating Pharmacodynamic Efficacy from Behavior with Neuroimaging
27. Learning to identify CNS drug action and efficacy using multistudy fMRI data
28. The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil
29. Hemodynamic effects during induction, laryngoscopy, and intubation with eltanolone (5β-pregnanolone) or propofol. A study in ASA I and II patients
30. Post-ischemic diastolic dysfunction
31. Graded myocardial ischemia is associated with a decrease in diastolic distensibility of the remote nonischemic myocardium in the anesthetized dog
32. Stimulus Site and Modality Dependence of Functional Activity within the Human Spinal Cord.
33. Neural Correlates of an Injury-Free Model of Central Sensitization Induced by Opioid Withdrawal in Humans.
34. "Consensus on Placebo and Nocebo Effects Connects Science with Practice:" Reply to "Questioning the Consensus on Placebo and Nocebo Effects".
35. What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.